World’s first synthetic intelligence (AI)-driven, augmented actuality (AR) steerage system for spine surgical procedure acknowledged by panel of main orthopedic surgeons.
DEERFIELD, In poor health., Oct. 11, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a world medical know-how firm targeted on elevating the usual of care by driving the evolution of digital well being, at this time introduced its HOLO Portal surgical steerage system gained the 2022 Finest New Backbone Expertise Award offered by Orthopedics This Week, probably the most extensively learn publication within the orthopedics business. The award will likely be offered on the North American Backbone Society (NASS) Annual Assembly in Chicago on October 13.
The annual Orthopedics This Week Backbone Expertise Awards acknowledge the following era of exemplary and progressive applied sciences designed to enhance spine care and the engineering groups and inventors who create them. Successful submissions are voted on by a panel of main surgeons with scientific and analysis expertise in robotics, cervical care, thoracolumbar care, movement preservation, minimally invasive spine care, and biomaterials and biologics. Successful submissions are judged based on originality, scientific relevance, scientific drawback fixing, chance of bettering affected person outcomes, and value effectiveness.
“The remedy of debilitating again ache is present process a major revolution when it comes to know-how and affected person outcomes,” stated Robin Younger, founder and writer of Orthopedics This Week. “The 2022 jury of senior spine and neurosurgeons voted Surgalign’s HOLO Portal the ‘Finest New Expertise of 2022.’ With the intention to win, HOLO Portal needed to persuade the jury it solved a present scientific drawback, improved affected person commonplace of care, was value efficient and “I might use it.” Congratulations to Surgalign’s engineering workers and scientists for this nice accomplishment.”
HOLO Portal is the world’s first surgical steerage system to include AI and AR. The system’s AI processes intraoperative pictures to autonomously section and label the anatomy and plan patient-specific pedicle screw trajectories which are permitted by the surgeon. The HOLO Portal system makes use of AR to overlay the segmented AI reconstruction over the affected person’s precise anatomy, offering real-time 3D visualization all through the surgical process. This AR show helps surgeons visualize trajectories and guides surgical devices.
In January 2022, the Firm acquired U.S. Food & Drug Administration (FDA) 510(ok) clearance to be used of the HOLO Portal system inside lumbar spine procedures. The Firm is at the moment increasing the system’s restricted market launch and intends to additional enhance its scientific website places all year long. As circumstances are carried out and information is amassed, the Firm additionally intends to combine new purposes on its platform to advance the standard of care and enhance outcomes for sufferers.
“It’s really an honor to obtain this prestigious award from Orthopedics This Week. It’s particularly validating that it was selected by a panel of distinguished spine and neurological surgeons,” stated Cristian Luciano, vp of analysis and improvement at Surgalign and a founding father of Holo Surgical Inc, the place HOLO Portal was first developed. “This recognition is a testomony to the devoted efforts of our gifted engineers, scientists, and physicians over the previous seven years. Coupled with the excellent scientific efficiency of the system up to now and constructive surgeon suggestions, this provides to our already excessive expectations as we work towards our purpose to enhance affected person outcomes and save lives with our AR and AI applied sciences.”
“We thank Orthopedics This Week and the panel of distinguished surgeon judges for recognizing the innovation of this know-how,” stated Terry Wealthy, president and CEO of Surgalign. “This peer recognition from main orthopedic and neurosurgeons and the most-read publication within the orthopedic business, is a testomony to the efforts of an excellent group of engineers, scientists and physicians. I couldn’t be prouder of their accomplishments up to now and the progress we’ve got revamped the previous yr to acquire 510(ok) clearance for HOLO Portal, additional our commercialization initiatives, and increase our attain. We’re excited to now debut the HOLO Portal system at business occasions, together with NASS.”
The Firm will likely be showcasing its HOLO Portal surgical steerage system (sales space #4841) in the course of the 37th Annual NASS Assembly on October 12-15, 2022, at McCormick Place-West Constructing in Chicago, IL.
About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a world medical know-how firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is actually potential for his or her sufferers. Surgalign is targeted on growing options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through america and in roughly 50 nations worldwide by way of an increasing community of high unbiased distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Study extra at www.surgalign.com and join on LinkedIn and Twitter.
Ahead Trying Assertion This press launch comprises forward-looking statements primarily based on administration’s present expectations, estimates and projections about our merchandise, firm, and business, our administration’s beliefs, and sure assumptions made by our administration. Phrases corresponding to “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and different variations of such phrases and comparable expressions are meant to determine such forward-looking statements. Ahead-looking statements embody statements relating to the options, capabilities and advantages of the HOLO Portal system. These statements usually are not ensures of future efficiency and are topic to dangers and uncertainties, together with the dangers described in our public filings with the U.S. Securities and Trade Fee (SEC). Our precise outcomes might differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of the corporate’s SEC filings could also be obtained by contacting the corporate or the SEC or by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov.